More colleges are embracing the need to coordinate medical research training from “bench to bedside” through clinical pharmacy and translational science. The National Institutes of Health has emphasized the importance of clinicians working on research with healthcare teams. There is a significant need for student pharmacists and other healthcare professional students to gain this advanced training as the “nation faces a critical decline of clinical scientists with experience in both patient care and research,” the NIH noted.
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is going one step further in its academic programs, becoming the only pharmacy school-based program of its kind in the country, offering a Master of Science degree program in clinical and translational therapeutics. “The synergy between pharmacy together with the clinical and translational sciences facilitated the creation of a new tailor-made program specifically focused on treatment optimization,” said Dr. Brian Tsuji, professor and associate dean for clinical and translational sciences.
Completion of the program, combined with a Pharm.D. or other health professions degrees, provides graduates with a “remarkable advantage when applying for residencies, fellowships or employment in clinical pharmacy or industry,” said the university. The program “offers five therapeutic areas of concentration: clinical trials, pharmacotherapy, translational pharmacology, experimental therapeutics and pharmaceutical outcomes. The tracks combine rotations with a pragmatic focus on research to create a highly individualized experience,” according to the university.
“UB has world-leading graduate training programs in pharmacokinetics and pharmacodynamics in the pharmaceutical sciences and an extremely innovative Pharm.D. curriculum,“ Tsuji said in a statement. “Our M.S. in clinical and translational therapeutics truly stands on the shoulders of giants.”